Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Q34372881)
Jump to navigation
Jump to search
scientific article published on September 30, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial |
scientific article published on September 30, 2010 |
Statements
1 reference
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (English)
1 reference
H-H Parving
1 reference
Y. Miao
D. Dobre
H. J Lambers Heerspink
B. M. Brenner
M. E. Cooper
S. Shahinfar
30 September 2010
1 reference
1 reference
54
1 reference
1
1 reference
44-50
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference